DalsnaFinance › IPOs › Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. completed its initial public offering on NASDAQ on October 11, 2018, pricing at $18.00 a share.
| Ticker | ALLO |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 11, 2018 |
| Offering price | $18.00 |
| Shares offered | 18,000,000 |
| Total raised | $324M |
Allogene Therapeutics, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.